ReviewLife (Basel, Switzerland)2026
When Macrophages Heal and When They Scar: Timing in Corneal Fibrosis.
Review in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Corneal fibrosis and scarring remain leading causes of vision impairment and blindness globally, particularly following trauma, infection, or surgical intervention. Macrophages, as central mediators of immune and repair responses, orchestrate key phases of corneal wound healing. Their functional states, ranging from pro-inflammatory to pro-resolving, are tightly regulated by environmental cues and timing. Following corneal injury, recruited macrophages undergo temporally distinct activation programs. Early inflammatory macrophage responses support debris clearance, pathogen defense, and initiation of stromal repair, whereas persistence of inflammatory and profibrotic macrophage signaling beyond the acute healing phase is associated with sustained TGF-β activity, fibroblast-to-myofibroblast differentiation, excessive extracellular matrix deposition, and stromal haze formation. Conversely, timely transition toward pro-resolving macrophage states promotes inflammation resolution, myofibroblast clearance, and restoration of corneal transparency. Recent single-cell transcriptomic profiling reveals substantial heterogeneity among macrophage populations in the cornea, highlighting the limitations of the oversimplified M1/M2 classification. This review aims to define how macrophage heterogeneity and temporal dynamics regulate corneal wound healing outcomes, with particular emphasis on the balance between fibrosis and regeneration, and to provide a conceptual framework relevant to both basic researchers and translational clinicians.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.